{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T14:11:28Z","timestamp":1693491088961},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/mjt.0b013e31827c5372","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T15:30:04Z","timestamp":1366126204000},"page":"e218-e223","source":"Crossref","is-referenced-by-count":2,"title":["Optimal Blood Pressure Goals in Patients With Hypertension at High Risk for Cardiovascular Events"],"prefix":"10.1097","volume":"23","author":[{"given":"Wilbert S.","family":"Aronow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-24-20210202","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":". The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R2-24-20210202","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","article-title":". ACCFAHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.","volume":"57","author":"Aronow","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R3-24-20210202","first-page":"e21","article-title":". Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"R4-24-20210202","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.amjcard.2008.08.037","article-title":". A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults.","volume":"103","author":"Aronow","year":"2009","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"R5-24-20210202","first-page":"S33","article-title":"Standards of medical care for patients with diabetes mellitus.","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"R6-24-20210202","first-page":"S1","article-title":"KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R7-24-20210202","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","article-title":". Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"key":"R8-24-20210202","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/08037050903450468","article-title":". Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.","volume":"18","author":"Mancia","year":"2009","journal-title":"Blood Press"},{"key":"R9-24-20210202","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":". Treatment of hypertension in patients 80 years of age or older.","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"R10-24-20210202","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/HYPERTENSIONAHA.111.177147","article-title":"Hypertension guidelines.","volume":"58","author":"Aronow","year":"2011","journal-title":"Hypertension"},{"key":"R11-24-20210202","first-page":"1835","article-title":"Kjeldsen SE, et al..","volume":"12","author":"Banach","year":"2011","journal-title":"What should be the optimal levels of blood pressure: does the J-curve phenomenon really exist Expert Opin Pharmacother"},{"key":"R12-24-20210202","first-page":"253","article-title":"Should we have any doubts about hypertension therapy in elderly patients. ACCFAHA 2011 expert consensus document on hypertension in the elderly.","volume":"121","author":"Banach","year":"2011","journal-title":"Pol Arch Med Wewn"},{"key":"R13-24-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08037051.2011.615902","article-title":"Ten most important things to learn from the ACCFAHA 2011 expert consensus document on hypertension in the elderly.","volume":"21","author":"Aronow","year":"2012","journal-title":"Blood Press"},{"key":"R15-24-20210202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/jhh.2012.3","article-title":"Hypertension therapy in the elderly-do we know the answers to all the questions The status after publication of the ACCFAHA 2011 expert consensus document on hypertension in the elderly.","volume":"26","author":"Banach","year":"2012","journal-title":"J Hum Hypertens"},{"key":"R16-24-20210202","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1161\/CIRCULATIONAHA.109.905687","article-title":". What is the optimal blood pressure in patients after acute coronary syndromes Relationship of blood pressure and cardiovascular events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 trial.","volume":"122","author":"Bangalore","year":"2010","journal-title":"Circulation"},{"key":"R17-24-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":". Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"R18-24-20210202","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus.","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"R19-24-20210202","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/CIRCULATIONAHA.110.008870","article-title":". Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET).","volume":"124","author":"Mancia","year":"2011","journal-title":"Circulation"},{"key":"R20-24-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2011.09.040","article-title":". Safety and efficacy of low blood pressures among patients with diabetes. Subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).","volume":"59","author":"Redon","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R21-24-20210202","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":". Intensive blood-pressure control in hypertensive chronic kidney disease.","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med"},{"key":"R22-24-20210202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.HYP.29.2.641","article-title":". Achievement and safety of a low blood pressure goal in chronic renal disease: the Modification of Diet in Renal Disease Study Group.","volume":"29","author":"Lazarus","year":"1997","journal-title":"Hypertension"},{"key":"R23-24-20210202","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":". Blood-pressure control for renoprotection in patients with nondiabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"R24-24-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier.","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Ann intern Med"},{"key":"R25-24-20210202","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2011.1650","article-title":". Level of systolic blood pressure within the normal range and risk of recurrent stroke.","volume":"306","author":"Ovbiagele","year":"2011","journal-title":"JAMA"},{"key":"R27-24-20210202","first-page":"703","article-title":"2 diabetes:UKPDS38.","volume":"317","year":"1998","journal-title":"B M J"},{"key":"R28-24-20210202","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":". Effects of intense blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial.","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"R29-24-20210202","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"ADVANCE Collaborative Group, MacMahon S, et al.. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"R30-24-20210202","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/HYPERTENSIONAHA.111.178178","article-title":". Isolated diastolic hypotension and incident heart failure in older adults.","volume":"58","author":"Guichard","year":"2011","journal-title":"Hypertension"},{"key":"R32-24-20210202","first-page":"591","article-title":"Might losartan reduce sudden cardiac death in diabetic patients with hypertension L","volume":"362","author":"Aronow","year":"2003","journal-title":"ancet"},{"key":"R33-24-20210202","first-page":"1684","article-title":"Atenolol in hypertension: is it a wise choice L","volume":"364","author":"Carlberg","year":"2004","journal-title":"ancet"},{"key":"R34-24-20210202","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1517\/14656566.2010.482561","article-title":"Current role of beta blockers in the treatment of hypertension.","volume":"11","author":"Aronow","year":"2010","journal-title":"Expert Opin Pharmacotherap"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e31827c5372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:37:39Z","timestamp":1620963459000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201601000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31827c5372","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}